Munitta joined the University as a Postdoctoral Scientist in the Immunobiology Research Unit. She has gone on to be an independent researcher and lecturer and was most recently appointed Professor of Immuno-oncology. She is a member of the American Association of Cancer Research (AACR), British Society of Immunology (BSI), European Macrophage and Dendritic Cell Society, British Association for Cancer Research, and British Society of Immunology. Prof Muthana has a long-standing track record of working with cancer-killing viruses. Her research on novel approaches to treating cancers through a ‘Trojan horse’ method to deliver medicine to tumors has culminated in an all-female spinout company, NanOncolytics.